Analysts’ Viewpoint
People aged 60 and above are expected to constitute around 25% of the global population by the year 2050. This is projected to significantly boost the diagnostic imaging equipment market demand during the forecast period. The geriatric population is at a greater risk of chronic ailments, which is prompting several government bodies to initiate awareness campaigns about preventive measures to be taken against chronic diseases.
Rise in prevalence of chronic diseases and demand for early detection of diseases is estimated to offer lucrative market opportunities to manufacturers in the next few years. Moreover, rapid innovations in imaging technology and favorable reimbursement policies are estimated to positively impact the diagnostic imaging market forecast in the near future.
Healthcare practitioners are extensively employing diagnostic imaging technologies to examine patients and diagnose their exact medical conditions. Diagnostic imaging is utilized to identify a wide range of issues, which include cardiac abnormalities, broken bones, aneurysms, gastrointestinal issues, and various types of cancer. It is also utilized to monitor the human body's response to treatment.
Diagnostic imaging is painless and offers rapid diagnosis. It also helps in exclusion of therapeutic treatments, thereby resulting in noticeable saving. Growing awareness about the importance of early diagnosis for the effective treatment of cancer is boosting the demand for cancer diagnosis. As per the British Heart Foundation data published in January 2022, coronary (ischemic) heart disease affected 200 million individuals. Peripheral arterial (vascular) disease affected 110 million, atrial fibrillation negatively impacted 60 million, and stroke affected 100 million people, worldwide, during the same period. Therefore, rise in incidence of cardiovascular diseases is likely to drive the diagnostic imaging market development.
Skilled professionals are needed to handle or operate diagnostic equipment. Untrained professionals could increase the hazards or risks associated with certain diagnostic equipment, such as prolonged exposure of patients to ultrasound energy or X-rays during diagnosis. According to the WHO, there is a significant shortage of skilled professionals to use diagnostic equipment. This is expected to hamper the market progress. Furthermore, high cost associated with diagnostic equipment is also anticipated to act as a key diagnostic imaging market restraint in the near future.
As per the World Health Organization (WHO), the year 2030 would see 1.4 billion people aged 60 and above; which would reach 2.1 billion by 2050. It’s a known fact that geriatric population is more prone to chronic ailments as compared to those aged below 60. This factor is expected to drive the diagnostic imaging industry during the forecast period.
The number of surgeries is increasing among the elderly population owing to rising incidence of trauma and injuries. This is driving the use of imaging equipment for effective and rapid medical intervention. Furthermore, rise in prevalence of cancer and cardiovascular diseases in the elderly population is boosting the demand for medical imaging systems across the globe.
As per Statista, in 2019, cardiovascular diseases, cancer, respiratory diseases, and diabetes accounted for 17.9 million, 9.3 million, 4.1 million, and 1.5 million deaths, respectively, worldwide. Growing awareness about these ailments is fueling the demand for early diagnosis. High preference for preventive measures as compared to curative measures, among the patient population, is further driving the demand for diagnostic imaging techniques.
Increase in awareness among the population about the availability of advanced diagnostic devices and rise in healthcare expenditure are driving the adoption of diagnostic imaging across the globe. Moreover, rise in investments by governments to expand and develop sophisticated healthcare infrastructure is projected to propel the diagnostic imaging industry growth during the forecast period.
North America held the largest diagnostic imaging market share in 2022, with the U.S. witnessing an increasing demand for advanced healthcare systems due to growing incidences of chronic ailments. According to the American Cancer Society, the U.S. registered 1.9 million new cancer cases in 2022. It further stated that the year 2021 saw 83,750 people getting diagnosed with brain and the other central nervous system-related tumors in the U.S. Moreover, one of the key diagnostic imaging industry trends witnessed in North America is the high rate of adoption of advanced technologies in the healthcare industry in the region.
Europe accounted for a notable share of the total global demand for diagnostic imaging due to increase in incidence of chronic disorders in the region. According to the Organization for Economic Co-Operation and Development, chronic ailments such as diabetes, strokes, heart attacks, and cancer account for more than 550,000 premature fatalities in Europe and cost over US$ 130 Bn to the overall economy.
The diagnostic imaging industry size in Asia Pacific is expected to grow at a rapid pace owing to a surge in incidence of cardiovascular diseases, which accounts for 20-30% of fatalities in Indonesia, Philippines, Thailand, Japan, Hong Kong, Malaysia, Korea, Japan, and urban China.
The global diagnostic imaging business is moderately fragmented. Leading players are emphasizing on various modes of expansion such as new product launch, mergers, acquisitions, partnerships, and joint ventures to consolidate their position in the global market. A few prominent entities operating in the global market include GE Healthcare, Koninklijke Philips N.V., Hologic, Inc., Siemens Healthcare GmbH, Fujifilm Corporation, Toshiba Medical Systems Corporation, Shimadzu Corporation, Carestream Health, Inc., Hitachi Ltd., and Samsung Medison.
Key players in the diagnostic imaging market report have been profiled based on various parameters such as company overview, business strategies, financial overview, product portfolio, and business segments.
| Attribute | Detail |
|---|---|
| Market Value in 2022 (Base Year) | US$ 17.1 Bn |
| Market Forecast Value in 2031 | US$ 25.7 Bn |
| Growth Rate (CAGR) | 4.7% |
| Forecast Period | 2023-2031 |
| Quantitative Units | US$ Bn for Value and Million Units for Volume |
| Market Analysis | Qualitative analysis includes drivers, restraints, opportunities, key trends, key market indicators, Porter’s Five Forces analysis, value chain analysis, and SWOT analysis. Furthermore, at the regional level, the qualitative analysis includes key trends, price trends, and key supplier analysis. |
| Competition Landscape | Prominent Players - Competition Dashboard and Revenue Share Analysis, 2022 Company Profiles (Details - Company Overview, Sales Area/Geographical Presence, Revenue, Strategy & Business Overview) |
| Regions Covered |
|
| Market Segmentation |
|
| Companies Profiled |
|
| Scope for Customization | Available upon Request |
| Pricing | Available upon Request |
The global market was valued at US$ 17.1 Bn in 2022
It is projected to grow at a CAGR of 4.7% from 2023 to 2031
Increase in geriatric population and rise in demand for early diagnosis of diseases
In terms of application, the cardiology segment held largest share in 2022
North America is estimated to dominate the global business in the next few years
GE Healthcare, Koninklijke Philips N.V., Hologic, Inc., Siemens Healthcare GmbH, Fujifilm Corporation, Toshiba Medical Systems Corporation, Shimadzu Corporation, Carestream Health, Inc., Hitachi Ltd., and Samsung Medison
1. Executive Summary
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Diagnostic Imaging Market
4. Market Overview
4.1. Market Segmentation
4.1.1. Segment Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Diagnostic Imaging Market Analysis and Forecast, 2022-2031
5. Key Insights
5.1. Pipeline Analysis
5.2. List of Types of Diagnostic Imaging Tests
5.3. Disease Prevalence & Incidence Rate Globally With Key Countries
5.4. COVID-19 Pandemic Impact on Industry
6. Diagnostic Imaging Market Analysis and Forecast, by Product
6.1. Introduction and Definitions
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Product, 2017-2031
6.3.1. X-Ray
6.3.2. MRI
6.3.3. Ultrasound
6.3.4. CT
6.3.5. Nuclear Imaging
6.4. Market Attractiveness, by Product
7. Diagnostic Imaging Market Analysis and Forecast, by Application
7.1. Introduction and Definitions
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Application, 2017-2031
7.3.1. Cardiology
7.3.2. Gynecology/Obs
7.3.3. Orthopedics & Musculoskeletal
7.3.4. Radiology
7.3.5. Neurology & Spine
7.3.6. General Imaging
7.3.7. Others
7.4. Market Attractiveness, by Application
8. Global Diagnostic Imaging Market Analysis and Forecast, by End-user
8.1. Introduction and Definitions
8.2. Key Findings/Developments
8.3. Market Value Forecast, by End-user, 2017-2031
8.3.1. Hospitals
8.3.2. Diagnostic Centers
8.3.3. Others
8.4. Market Attractiveness, by End-user
9. Global Diagnostic Imaging Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region, 2017-2031
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness, by Region
10. North America Diagnostic Imaging Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product, 2017-2031
10.2.1. X-Ray
10.2.2. MRI
10.2.3. Ultrasound
10.2.4. CT
10.2.5. Nuclear Imaging
10.3. Market Attractiveness, by Product
10.4. Market Value Forecast, by Application, 2017-2031
10.4.1. Cardiology
10.4.2. Gynecology/Obs
10.4.3. Orthopedics & Musculoskeletal
10.4.4. Radiology
10.4.5. Neurology & Spine
10.4.6. General Imaging
10.4.7. Others
10.5. Market Attractiveness, by Application
10.6. Market Value Forecast, by End-user, 2017-2031
10.6.1. Hospitals
10.6.2. Diagnostic Centers
10.6.3. Others
10.7. Market Attractiveness, by End-user
10.8. Market Value Forecast, by Country, 2022-2031
10.8.1. U.S.
10.8.2. Canada
10.9. Market Attractiveness Analysis
10.9.1. By Product
10.9.2. By Application
10.9.3. By End-user
10.9.4. By Country
11. Europe Diagnostic Imaging Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product, 2017-2031
11.2.1. X-Ray
11.2.2. MRI
11.2.3. Ultrasound
11.2.4. CT
11.2.5. Nuclear Imaging
11.3. Market Attractiveness, by Product
11.4. Market Value Forecast, by Application, 2017-2031
11.4.1. Cardiology
11.4.2. Gynecology/Obs
11.4.3. Orthopedics & Musculoskeletal
11.4.4. Radiology
11.4.5. Neurology & Spine
11.4.6. General Imaging
11.4.7. Others
11.5. Market Attractiveness, by Application
11.6. Market Value Forecast, by End-user, 2017-2031
11.6.1. Hospitals
11.6.2. Diagnostic Centers
11.6.3. Others
11.7. Market Attractiveness, by End-user
11.8. Market Value Forecast, by Country/Sub-region, 2022-2031
11.8.1. Germany
11.8.2. U.K.
11.8.3. France
11.8.4. Italy
11.8.5. Spain
11.8.6. Rest of Europe
11.9. Market Attractiveness Analysis
11.9.1. By Product
11.9.2. By Application
11.9.3. By End-user
11.9.4. By Country/Sub-region
12. Asia Pacific Diagnostic Imaging Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product, 2017-2031
12.2.1. X-Ray
12.2.2. MRI
12.2.3. Ultrasound
12.2.4. CT
12.2.5. Nuclear Imaging
12.3. Market Attractiveness, by Product
12.4. Market Value Forecast, by Application, 2017-2031
12.4.1. Cardiology
12.4.2. Gynecology/Obs
12.4.3. Orthopedics & Musculoskeletal
12.4.4. Radiology
12.4.5. Neurology & Spine
12.4.6. General Imaging
12.4.7. Others
12.5. Market Attractiveness, by Application
12.6. Market Value Forecast, by End-user, 2017-2031
12.6.1. Hospitals
12.6.2. Diagnostic Centers
12.6.3. Others
12.7. Market Attractiveness, by End-user
12.8. Market Value Forecast, by Country/Sub-region, 2017-2031
12.8.1. China
12.8.2. Japan
12.8.3. India
12.8.4. Australia & New Zealand
12.8.5. Rest of Asia Pacific
12.9. Market Attractiveness Analysis
12.9.1. By Product
12.9.2. By Application
12.9.3. By End-user
12.9.4. By Country/Sub-region
13. Latin America Diagnostic Imaging Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product, 2017-2031
13.2.1. X-Ray
13.2.2. MRI
13.2.3. Ultrasound
13.2.4. CT
13.2.5. Nuclear Imaging
13.3. Market Attractiveness, by Product
13.4. Market Value Forecast, by Application, 2017-2031
13.4.1. Cardiology
13.4.2. Gynecology/Obs
13.4.3. Orthopedics & Musculoskeletal
13.4.4. Radiology
13.4.5. Neurology & Spine
13.4.6. General Imaging
13.4.7. Others
13.5. Market Attractiveness, by Application
13.6. Market Value Forecast, by End-user, 2017-2031
13.6.1. Hospitals
13.6.2. Diagnostic Centers
13.6.3. Others
13.7. Market Attractiveness, by End-user
13.8. Market Value Forecast, by Country/Sub-region, 2017-2031
13.8.1. Brazil
13.8.2. Mexico
13.8.3. Rest of Latin America
13.9. Market Attractiveness Analysis
13.9.1. By Product
13.9.2. By Application
13.9.3. By End-user
13.9.4. By Country/Sub-region
14. Middle East & Africa Diagnostic Imaging Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product, 2017-2031
14.2.1. X-Ray
14.2.2. MRI
14.2.3. Ultrasound
14.2.4. CT
14.2.5. Nuclear Imaging
14.3. Market Attractiveness, by Product
14.4. Market Value Forecast, by Application, 2017-2031
14.4.1. Cardiology
14.4.2. Gynecology/Obs
14.4.3. Orthopedics & Musculoskeletal
14.4.4. Radiology
14.4.5. Neurology & Spine
14.4.6. General Imaging
14.4.7. Others
14.5. Market Attractiveness, by Application
14.6. Market Value Forecast, by End-user, 2017-2031
14.6.1. Hospitals
14.6.2. Diagnostic Centers
14.6.3. Others
14.7. Market Attractiveness, by End-user
14.8. Market Value Forecast, by Country/Sub-region, 2017-2031
14.8.1. GCC Countries
14.8.2. South Africa
14.8.3. Rest of Middle East & Africa
14.9. Market Attractiveness Analysis
14.9.1. By Product
14.9.2. By Application
14.9.3. By End-user
14.9.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competition Matrix (By Tier and Size of Companies)
15.2. Market Share Analysis, by Company (2022)
15.3. Company Profiles
15.3.1. GE Healthcare
15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2. Product Portfolio
15.3.1.3. Financial Overview
15.3.1.4. SWOT Analysis
15.3.1.5. Strategic Overview
15.3.2. Koninklijke Philips N.V.
15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.2.2. Product Portfolio
15.3.2.3. Financial Overview
15.3.2.4. SWOT Analysis
15.3.2.5. Strategic Overview
15.3.3. Hologic, Inc.
15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.3.2. Product Portfolio
15.3.3.3. Financial Overview
15.3.3.4. SWOT Analysis
15.3.3.5. Strategic Overview
15.3.4. Siemens Healthcare GmbH
15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.4.2. Product Portfolio
15.3.4.3. Financial Overview
15.3.4.4. SWOT Analysis
15.3.4.5. Strategic Overview
15.3.5. Fujifilm Corporation
15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.5.2. Product Portfolio
15.3.5.3. Financial Overview
15.3.5.4. SWOT Analysis
15.3.5.5. Strategic Overview
15.3.6. Toshiba Medical Systems Corporation
15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2. Product Portfolio
15.3.6.3. Financial Overview
15.3.6.4. SWOT Analysis
15.3.6.5. Strategic Overview
15.3.7. Shimadzu Corporation
15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.7.2. Product Portfolio
15.3.7.3. Financial Overview
15.3.7.4. SWOT Analysis
15.3.7.5. Strategic Overview
15.3.8. Carestream Health, Inc.
15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.8.2. Product Portfolio
15.3.8.3. Financial Overview
15.3.8.4. SWOT Analysis
15.3.8.5. Strategic Overview
15.3.9. Hitachi Ltd.
15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.9.2. Product Portfolio
15.3.9.3. Financial Overview
15.3.9.4. SWOT Analysis
15.3.9.5. Strategic Overview
15.3.10. Samsung Medison
15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.10.2. Product Portfolio
15.3.10.3. Financial Overview
15.3.10.4. SWOT Analysis
15.3.10.5. Strategic Overview
List of Tables
Table 01: Global Diagnostic Imaging Market Value (US$ Mn) Forecast, by Product, 2017-2031
Table 02: Global Diagnostic Imaging Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 03: Global Diagnostic Imaging Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 04: Global Diagnostic Imaging Market Value (US$ Mn) Forecast, by Region, 2017-2031
Table 05: North America Diagnostic Imaging Market Value (US$ Mn) Forecast, by Country, 2017-2031
Table 06: North America Diagnostic Imaging Market Value (US$ Mn) Forecast, by Product, 2017-2031
Table 07: North America Diagnostic Imaging Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 08: North America Diagnostic Imaging Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 09: Europe Diagnostic Imaging Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 10: Europe Diagnostic Imaging Market Value (US$ Mn) Forecast, by Product, 2017-2031
Table 11: Europe Diagnostic Imaging Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 12: Europe Diagnostic Imaging Market Value (US$ Mn) Forecast, by End-user 2017-2031
Table 13: Asia Pacific Diagnostic Imaging Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 14: Asia Pacific Diagnostic Imaging Market Value (US$ Mn) Forecast, by Product, 2017-2031
Table 15: Asia Pacific Diagnostic Imaging Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 16: Asia Pacific Diagnostic Imaging Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 17: Latin America Diagnostic Imaging Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 18: Latin America Diagnostic Imaging Market Value (US$ Mn) Forecast, by Product, 2017-2031
Table 19: Latin America Diagnostic Imaging Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 20: Latin America Diagnostic Imaging Market Value (US$ Mn) Forecast, by End-user 2017-2031
Table 21: Middle East & Africa Diagnostic Imaging Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 22: Middle East & Africa Diagnostic Imaging Market Value (US$ Mn) Forecast, by Product, 2017-2031
Table 23: Middle East & Africa Diagnostic Imaging Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 24: Middle East & Africa Diagnostic Imaging Market Value (US$ Mn) Forecast, by End-user 2017-2031
List of Figures
Figure 01: Global Diagnostic Imaging Market Value (US$ Mn) Forecast, 2017-2031
Figure 02: Global Diagnostic Imaging Market Value Share, by Product, 2022
Figure 03: Global Diagnostic Imaging Market Value Share, by Application, 2022
Figure 04: Global Diagnostic Imaging Market Value Share, by End-user, 2022
Figure 05: Global Diagnostic Imaging Market Value Share Analysis, by Product, 2022 and 2031
Figure 06: Global Diagnostic Imaging Market Attractiveness Analysis, by Product, 2023-2031
Figure 07: Global Diagnostic Imaging Market Value Share Analysis, by Application, 2022 and 2031
Figure 08: Global Diagnostic Imaging Market Attractiveness Analysis, by Application, 2023-2031
Figure 09: Global Diagnostic Imaging Market Value Share Analysis, by End-user, 2022 and 2031
Figure 10: Global Diagnostic Imaging Market Attractiveness Analysis, by End-user 2023-2031
Figure 11: Global Diagnostic Imaging Market Value Share Analysis, by Region, 2022 and 2031
Figure 12: Global Diagnostic Imaging Market Attractiveness Analysis, by Region, 2023-2031
Figure 13: North America Diagnostic Imaging Market Value (US$ Mn) Forecast, 2017-2031
Figure 14: North America Diagnostic Imaging Market Value Share Analysis, by Country, 2022 and 2031
Figure 15: North America Diagnostic Imaging Market Attractiveness Analysis, by Country, 2023-2031
Figure 16: North America Diagnostic Imaging Market Value Share Analysis, by Product, 2022 and 2031
Figure 17: North America Diagnostic Imaging Market Attractiveness Analysis, by Product, 2023-2031
Figure 18: North America Diagnostic Imaging Market Value Share Analysis, by Application, 2022 and 2031
Figure 19: North America Diagnostic Imaging Market Attractiveness Analysis, by Application, 2023-2031
Figure 20: North America Diagnostic Imaging Market Value Share Analysis, by End-user, 2022 and 2031
Figure 21: North America Diagnostic Imaging Market Attractiveness Analysis, by End-user 2023-2031
Figure 22: Europe Diagnostic Imaging Market Value (US$ Mn) Forecast, 2017-2031
Figure 23: Europe Diagnostic Imaging Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 24: Europe Diagnostic Imaging Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
Figure 25: Europe Diagnostic Imaging Market Value Share Analysis, by Product, 2022 and 2031
Figure 26: Europe America Diagnostic Imaging Market Attractiveness Analysis, by Product, 2023-2031
Figure 27: Europe Diagnostic Imaging Market Value Share Analysis, by Application, 2022 and 2031
Figure 28: Europe Diagnostic Imaging Market Attractiveness Analysis, by Application, 2023-2031
Figure 29: Europe Diagnostic Imaging Market Value Share Analysis, by End-user, 2022 and 2031
Figure 30: Europe Diagnostic Imaging Market Attractiveness Analysis, by End-user 2023-2031
Figure 31: Asia Pacific Diagnostic Imaging Market Value (US$ Mn) Forecast, 2017-2031
Figure 32: Asia Pacific Diagnostic Imaging Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 33: Asia Pacific Diagnostic Imaging Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
Figure 34: Asia Pacific Diagnostic Imaging Market Value Share Analysis, by Product, 2022 and 2031
Figure 35: Asia Pacific America Diagnostic Imaging Market Attractiveness Analysis, by Product, 2023-2031
Figure 36: Asia Pacific Diagnostic Imaging Market Value Share Analysis, by Application, 2022 and 2031
Figure 37: Asia Pacific Diagnostic Imaging Market Attractiveness Analysis, by Application, 2023-2031
Figure 38: Asia Pacific Diagnostic Imaging Market Value Share Analysis, by End-user, 2022 and 2031
Figure 39: Asia Pacific Diagnostic Imaging Market Attractiveness Analysis, by End-user 2023-2031
Figure 40: Latin America Diagnostic Imaging Market Value (US$ Mn) Forecast, 2017-2031
Figure 41: Latin America Diagnostic Imaging Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 42: Latin America Diagnostic Imaging Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
Figure 43: Latin America Diagnostic Imaging Market Value Share Analysis, by Product, 2022 and 2031
Figure 44: Latin America Diagnostic Imaging Market Attractiveness Analysis, by Product, 2023-2031
Figure 45: Latin America Diagnostic Imaging Market Value Share Analysis, by Application, 2022 and 2031
Figure 46: Latin America Diagnostic Imaging Market Attractiveness Analysis, by Application, 2023-2031
Figure 47: Latin America Diagnostic Imaging Market Value Share Analysis, by End-user, 2022 and 2031
Figure 48: Latin America Diagnostic Imaging Market Attractiveness Analysis, by End-user, 2023-2031
Figure 49: Middle East & Africa Diagnostic Imaging Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 50: Middle East & Africa Diagnostic Imaging Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
Figure 51: Middle East & Africa America Diagnostic Imaging Market Value Share Analysis, by Product, 2023-2031
Figure 52: Middle East & Africa America Diagnostic Imaging Market Attractiveness Analysis, by Product, 2023-2031
Figure 53: Middle East & Africa Diagnostic Imaging Market Value Share Analysis, by End-user, 2022 and 2031
Figure 54: Middle East & Africa Diagnostic Imaging Market Attractiveness Analysis, by End-user 2023-2031
Figure 55: Global Diagnostic Imaging Market Share Analysis, by Company (2022)
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Diagnostic Imaging Market
